Prostate Cancer
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer - Abstract
October 24, 2014
Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment - Abstract
October 23, 2014
Practice patterns and individual variability of surgeons performing radical prostatectomies at a high volume academic center - Abstract
October 23, 2014
Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer - Abstract
October 23, 2014
Metastatic prostate adenocarcinoma posing as urothelial carcinoma of the right ureter: A case report and literature review - Abstract
October 23, 2014
Prostate cancer: What treatment techniques for which tumors? Ethical and methodological issues - Abstract
October 23, 2014
Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population - Abstract
October 23, 2014
Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer - Abstract
October 23, 2014
Use of PDE5-inhibitors may adversely impact biochemical recurrence following radical prostatectomy - Abstract
October 23, 2014
Increasing use of observation among men at low risk for prostate cancer mortality - Abstract
October 23, 2014
Treatment of localized prostate cancer by vascular-targeted photodynamic therapy with WST11 - Abstract
October 22, 2014
Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: Who, when, where and how? - Abstract
October 22, 2014